UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer
Condition(s):Rectal Cancer Stage IIILast Updated:December 8, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Rectal Cancer Stage IIILast Updated:December 8, 2021Recruiting
Condition(s):Locally Advanced Rectal CancerLast Updated:September 15, 2023Recruiting
Condition(s):Rectal CancerLast Updated:July 18, 2022Withdrawn
Condition(s):LOCALLY ADVANCED RECTAL CANCERLast Updated:September 27, 2018Recruiting
Condition(s):Locally Advanced Rectal CancerLast Updated:December 11, 2020Not yet recruiting
Condition(s):Locally Advanced Rectal CancerLast Updated:February 22, 2023Terminated
Condition(s):Locally Advanced Rectal CancerLast Updated:May 31, 2023Recruiting
Condition(s):Locally Advanced Rectal CancerLast Updated:August 8, 2023Not yet recruiting
Condition(s):Locally Advanced Rectal CancerLast Updated:November 1, 2022Recruiting
Condition(s):Locally Advanced Rectal Cancer; Abdominoperineal ResectionLast Updated:April 3, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.